Perrigo Rx Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Perrigo rx pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Perrigo Rx Pharmaceuticals Today - Breaking & Trending Today

Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration

Share this article
Share this article
DUBLIN, March 1, 2021 /PRNewswire/ Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of
Consumer Self-Care Products, announced today that it has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for total consideration of $1.55 billion, including $1.5 billion in cash, subject to customary adjustments. As part of the consideration, Altaris will also assume more than $50 million in potential R&D milestone payments and contingent purchase obligations with third-party Rx partners.
Perrigo CEO and President Murray S. Kessler commented, The sale of our Generic Rx business is the most impactful step in Perrigo s transformation plan. This transaction establishes Perrigo as a pure-play global consumer self-care company with industry leading fundamentals. Perrigo Consumer Self-Care will have a focused portfolio with over $4 billion in revenues focused on ....

United States , Cleary Gottlieb , Rosen Katz , George Aitken Davies , Garikai Nyaruwata , Murrays Kessler , Schiff Hardin , Generic Rx Pharmaceuticals , Perrigo Rx Pharmaceuticals , Exchange Commission , Company Form , While The Company , Altaris Capital Partners , Perrigo Company , Goldman Sachs Co , Us Internal Revenue Service , Consumer Self Care Products , President Murray , Consumer Self Care , Managing Director , Lead Left Arranger , Goldman Sachs , Affordable Self Care Products , Proposed Assessment , Revenue Service , United States Securities ,

Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration

Perrigo Announces Agreement To Sell Generic Rx Business For $1.55 Billion In Total Consideration
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Cleary Gottlieb , Rosen Katz , George Aitken Davies , Garikai Nyaruwata , Murrays Kessler , Schiff Hardin , Generic Rx Pharmaceuticals , Perrigo Rx Pharmaceuticals , Exchange Commission , Company Form , While The Company , Altaris Capital Partners , Perrigo Company , Goldman Sachs Co , Us Internal Revenue Service , Consumer Self Care Products , President Murray , Consumer Self Care , Managing Director , Lead Left Arranger , Goldman Sachs , Affordable Self Care Products , Proposed Assessment , Revenue Service , United States Securities ,